Development of the lipid-rich core in human atherosclerosis.
about
Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery diseaseFrom Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismMacrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromesLRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol exportStabilizing role of platelet P2Y(12) receptors in shear-dependent thrombus formation on ruptured plaquesPlasmin promotes foam cell formation by increasing macrophage catabolism of aggregated low-density lipoprotein.Novel approaches to treating cardiovascular disease: lessons from Tangier disease.Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A.Interaction of functional NPC1 gene polymorphism with smoking on coronary heart diseaseCholesterol in the retina: the best is yet to come.Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathwayMinimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation.Quantification in situ of crystalline cholesterol and calcium phosphate hydroxyapatite in human atherosclerotic plaques by solid-state magic angle spinning NMR.Lipid mediators that modulate the extracellular matrix structure and function in vascular cells.Atherothrombosis in diabetes--its evolution and management.Aging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Beneath the minerals, a layer of round lipid particles was identified to mediate collagen calcification in compact bone formationAn agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production.Symptomatic and asymptomatic carotid artery plaqueEffect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis.Vascular proteomics: linking proteomic and metabolomic changes.Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor.Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatinFormulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles.The oil spill in ageing Bruch membrane.Sphingolipid metabolism and obesity-induced inflammation.Size-selective uptake of colloidal low density lipoprotein aggregates by cultured white blood cellsRapid regression of atherosclerosis: insights from the clinical and experimental literature.Inflammation and plaque vulnerability.Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophagesRabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.Liver-specific deficiency of serine palmitoyltransferase subunit 2 decreases plasma sphingomyelin and increases apolipoprotein E levels.Necrotic cell death in atherosclerosis.Heme on innate immunity and inflammation.Effects of pomegranate peel polyphenols on lipid accumulation and cholesterol metabolic transformation in L-02 human hepatic cells via the PPARγ-ABCA1/CYP7A1 pathway.Different effects of atherogenic lipoproteins and blood pressure on arterial structure and function: the Bogalusa Heart Study.
P2860
Q25255535-55C5206F-BD2D-4883-8BF6-73F48F993178Q28067617-0DC6735A-19F6-41B0-BDC4-7C54A9EE6908Q28359694-C79798CF-FF46-44DE-8AFA-D2CD3871B9DFQ28506509-1659F16A-F497-4A0D-9347-13298AF11099Q28752603-9B42C86B-E215-4CA6-B582-092677B411E2Q30541611-6916DA1F-BBBD-4B33-AF62-C3227317566FQ32066326-191A4E88-4DD0-43A7-B3DE-8BECC01DA6FBQ33286823-7B2C2A35-3EA3-40FE-8FF3-E109CB3E2822Q33721375-68FC6000-33BE-40A3-A81E-0F2B1F14F52CQ33758267-117AA646-FA4B-424A-AC2C-ACF1E0787848Q33883485-5D2FF5C0-5D98-459C-959A-45619E51E6DFQ33945076-BB92CC66-F11B-4789-AD22-CC3D9C3F13DFQ34105529-7B30730E-8F0C-4E2F-ABDE-D36B6FC6BB19Q34107223-93755D92-61D5-4964-B842-2938F398FB19Q34164126-84CE68AA-7921-48CD-90E6-31CA3F710232Q35056603-D1CDC260-6CC7-40B5-800E-5B5E9D1E8604Q35128968-E2F8FBF3-E604-4EF9-8870-4F6A24A6B166Q35147977-D08FDCEE-872B-458C-9CFF-E700B066C2F3Q35626038-A0DC146C-FAD1-44CF-9C39-EE952E8B2FADQ35769055-751185B6-0A28-4CDE-9F0A-7C1EC10ED142Q35918384-68A249F2-CC59-4F77-9657-29E23471935AQ35946897-EBF7B68E-5F29-41D7-AEF1-C52D200EF461Q36055034-2861885C-5217-4E07-A240-F79DFF8547E2Q36320445-06AD5A0E-6BB0-4642-A844-50062A865D47Q36396314-45C57257-BB9D-48D1-A903-414BE2B96E06Q36731084-8AE1CC1D-A072-4E69-B02A-8AE7453D4EB0Q36787937-7E50DFA5-57C7-4669-AA64-89387A226E0EQ36898608-6C202D33-91A2-4209-9692-72B4B714114DQ37036917-C42D2D61-562D-46D4-88BF-2D7857958E38Q37068628-3B8F9DCF-5173-424D-AC30-D14C7F7032A7Q37307660-E1A5A9D2-DEC7-4580-9165-7183F8B289FAQ37341571-DD418946-E8C8-4DC9-B50D-391C1ECCC7EDQ37359981-FABEA4A0-F698-451A-BAB8-F463AE3E6F58Q37371207-BFF17159-AECD-4CF5-B7BC-45A422CF9665Q37378380-1EF2FF4D-AEAB-4A6A-9B2B-842F91AFE6E0Q37446891-1C49D0C6-17B9-4888-9733-DD2E876AB5E5Q37879605-75FB4BB9-D338-470C-B5B9-4DCE3498FF08Q38218093-D16AC04F-D8A9-4EE0-BC17-4E2AEBA69425Q38731000-C7DAFEBE-8124-4FE5-9AF6-D62D1225F645Q38942264-AF0B21C7-D5DF-4D1D-9BC8-AF9D80707F19
P2860
Development of the lipid-rich core in human atherosclerosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Development of the lipid-rich core in human atherosclerosis.
@en
type
label
Development of the lipid-rich core in human atherosclerosis.
@en
prefLabel
Development of the lipid-rich core in human atherosclerosis.
@en
P356
P1476
Development of the lipid-rich core in human atherosclerosis.
@en
P2093
P356
10.1161/01.ATV.16.1.4
P407
P577
1996-01-01T00:00:00Z